VENN STRATEGIES

Lobbying for ELI LILLY AND COMPANY · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

General Healthcare issues, including drug accessibility, importation and innovation policies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.